HomeASIANPAINT › Filing
🔔 Get instant alerts when ASIANPAINT files quarterly results on BSE Start free trial →
ASIAN PAINTS LTD. (ASIANPAINT)

Investor Presentation

Filed: 29 May 2026, 16:57 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Q4FY26 standalone net sales grew 10.3%, gross margin 45.6%, PBDIT margin 21.2%, PAT +32.7% yoy - Consolidated Q4FY26 net sales +10.8%, gross margin 44.7%, PBDIT margin 19.4%, PAT +34.1% yoy - International business Q4 growth 11% INR, PBT margin improved 370 bps to 8.5% - Industrial segment revenue growth 15-21% in Q4; PBT margin mixed - FY26 dividend total ₹27.50/share, payout 60% - Outlook Q1FY27: steady demand, pricing actions to offset RM inflation and currency risks
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ASIANPAINT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ASIANPAINT to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on ASIAN PAINTS LTD.

Important. The summary above is generated automatically from ASIAN PAINTS LTD.'s own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.